PerpEquities

Equity · Healthcare

Twist Bioscience Corporation (TWST) perpetual futures

TWST perpetual futures on 16 crypto exchanges – live perp price vs the stock, funding rate, open interest and where to trade TWSTUSDT.

Twist Bioscience is a synthetic biology company that sells synthetic genes, antibody libraries, sample-preparation tools and DNA-based data storage products, and collaborates with pharma and genomics partners.

$105.80-0.1%NASDAQ closed
Open in terminal

Price chart

 

Use the left and right arrow keys to inspect points on the chart.

venue perp mark · Ourbit (TWST/USDT)
Auto: highest-volume live perp venueOpen in TradingView

Trading data

Perpetual market activity

16/16 live markets
Venues
16
Live markets
16/16
24h volume
$1.2MCoverage: 15/16 marketsExchange-reported volume: $2.9M
Open interest
$2MCoverage: 14/16 markets
Best liquidity
$1.8M
LBank
Tightest spread
+0.9 bps
Bitunix
Highest volume
$647.8K
LBank
Settlement mix
USDT · 14/16
Perp/spot vol.
0.00x
Spot volume $357.5M
OI / float
+0.03%
Float $7B
Spot performance
1D-7.44%
5D-2.52%
1M-23.73%
6M+70.58%
YTD+225.73%
1Y+252.27%

Venue matrix

16 markets

Some venue links are sponsored. We may receive a commission, and eligible users may occasionally receive trading-fee discounts, at no additional cost to you.

Trade
KuCoinTradeTWST/USDTTrading$105.780.0% APR
0.000% every 8h
+25.5 bps$2.9K$207.2K$3.4KUSDT20x
MEXCTradeTWST/USDTTrading$105.780.0% APR
0.000% every 8h
+4.7 bps$43.4K$101.8K$1.5MUSDT20x
BitunixTradeTWST/USDTTrading$105.80-6.2% APR
-0.00567% every 8h
+0.9 bps$100.4K$70.7K$44.7KUSDT20x
BingXTradeTWST-USDTTrading$105.80+5.5% APR
+0.00500% every 8h
+2.8 bps$32.9K$37.2K$307.6USDT-
HTXTradeTWST/USDTTrading$105.810.0% APR
0.000% every 8h
+86.0 bps$163K$34.6K$7.5KUSDT-
XT.comTradeTWST/USDTTrading$105.81+11.0% APR
+0.010% every 8h
+17.0 bps$15K$33K-USDT20x
BinanceTradeTWST/USDTTrading$105.810.0% APR
0.000% every 8h
+1.9 bps$28.1K$32.6K$109.8KUSDT-
BitgetTradeTWST/USDTTrading$105.770.0% APR
0.000% every 8h
+5.7 bps$209.5K$30.7K$87.2KUSDT20x
OKXTradeTWST/USDTTrading$105.850.0% APR
0.000% every 8h
+35.0 bps$4.7K$8K$31.3KUSDT20x
BloFinTradeTWST/USDTTrading$105.81+2.6% APR
+0.00240% every 8h
+2.8 bps$24.6K$7.4K$6.6KUSDT20x
BybitTradeTWST/USDTTrading$105.680.0% APR
0.000% every 8h
+24.6 bps$5.8K$4K$53KUSDT25x
Hyperliquid HIP-3Tradexyz:TWSTTrading$105.35+194.5% APR
+0.022% every 1h
+13.3 bps$13K$3.4K$78.9KUSDC10x
Gate.ioTradeTWST/USDTTrading$105.770.0% APR
0.000% every 8h
+129.8 bps$6.7K$542$14.8KUSDT20x
Crypto.com ExchangeTradeTWST/USDTrading$105.51+5.0% APR
+0.00057% every 1h
+10.4 bps$2.6K$0$668.9USD50x
LBankTradeTWST/USDTTrading$105.800.0% APR
0.000% every 8h
+18.9 bps$1.8M$647.8K-USDT50x
OurbitTradeTWST/USDTTrading$105.800.0% APR
0.000% every 8h
+18.9 bps$37.1K$1.7M⚠$115KUSDT20x

Unverified volume: implausibly high against open interest, a typical sign of wash trading. These venues are listed last.

Tradability

Execution quality

Entry cost and depth per venue at $1k–$100k

Broad liquidity · 12 of 16 venues absorb $10k · Typical cost: +24.3 bps – +54.2 bps

Cheapest execution: LBank · +7.9 bps

Too thin: Bybit, OKX, KuCoin, Crypto.com Exchange

Taker execution estimate incl. approx. fees - maker fills are not guaranteed.

Best venues for this underlying

Best liquidity

TWST

Tightest spread

TWST

Highest volume

TWST

Funding history

Stored venue snapshots by market

Company financials

Financials at a glance

Last report Q4 '26 · filed 2026-11-16 · next report 2027-02-01 · Updated 5h ago
All financials →

Valuation & key figures

Market cap
$7.04B
Updated 5h ago
Revenue
$459M
Trailing 12 months
Revenue growth
+21%
FY2027 consensus
Profit margin
-28.3%
Net income / revenue, TTM
P/E
No P/E
Loss in the last twelve months
P/S
15.3×
Price / sales, TTM
Peer P/E
37.9×
Similar listed perps
EV / EBITDA
-50.9×
TTM
Free cash flow
-$89M
Trailing 12 months
Net income
-$130M
Trailing 12 months
Revenue estimate
$556M
FY2027 consensus
Earnings
2027-02-01
Revenue est. $131M · Updated 5h ago
Dividend
–
No dividend
Revenue (TTM)$459M+22.0% vs a year agoLast 4 quarters; bars = each quarter
Operating margin (TTM)-30.4%+5.8 pp vs a year agoOperating income -$139M
Net income (TTM)-$130M-67.6% vs a year agoAfter tax, incl. non-operating gains
Free cash flow (TTM)-$89M-17.7% vs a year agoCapex $47.6M
Diluted EPS (TTM)-$2.08-58.8% vs a year agoSum of the last 4 quarters
Net cash$487M+411.9% vs a year agoCash + short-term investments - debt
  • Last report (2026-11-12): revenue beat by 2.5%, EPS beat by 17.3%Revenue $127M vs $124M expected (+2.5%); EPS -$0.32 vs -$0.39 (+17.3%).
  • Revenue growth accelerating: 27.9% year on yearQ4 '26 revenue $127M, against an average of 19.1% over the four quarters before.
  • Operating margin -30.4% (TTM), +5.8 pp on a year agoOperating income grew -2.3% while revenue grew 22.0%.
  • Capex 10.4% of revenue (a year ago 7.4%)$47.6M invested in the last 4 quarters (+69.9% on a year earlier). Free cash flow -$89M.

Revenue, operating income and growth

quarterly

Revenue by business line

Q3 '26
LineRevenuey/yShare of listed
Ngs Tools$61.8M+11.8%52.2%
Antibody Discovery$56.6M+907.7%47.8%
In the full financialsIncome statement, balance sheet and cash flow (12 quarters / 10 years) · margins and cost structure · capital allocation and buybacks · valuation against the 5-year range · analyst estimates · all 263 lines Twist Bioscience Corporation reported to the SEC

Next catalyst

Catalysts

Earnings
2027-02-01
Revenue est. $131M · Updated 5h ago

No unusual perp activity right now.

Research data

Analysts, filings and peer context

Estimates

6
DateEPS estimateRevenue estimateGrowthAnalysts
FY 2026-2.15$456.4M+21%5
FY 2027-1.37$556M+21%5
FY 2028-0.94$659.6M+19%5
FY 2029-0.25$782.4M+19%5
FY 20301.06$1B+33%3
FY 20312.43$1.3B+28%4
Source: FMP · Consensus

Company events

6
2027-02-01EarningsActual - / Estimate -0.35-
2026-11-12Earnings · Before market openActual -0.32 / Estimate -0.387Beat
2026-08-03EarningsActual -0.56 / Estimate -0.506Miss
2026-05-04EarningsActual -0.71 / Estimate -0.49Miss
2026-02-02EarningsActual -0.5 / Estimate -0.48Miss
2025-11-14EarningsActual -0.45 / Estimate -0.5Beat

Peer comparison

Similar listed perps

Company data

Company intelligence

Updated: Nov 21, 2026, 07:45 PM UTC

Company profile

Sector
Healthcare
Industry
Biotechnology
Chief executive
Emily Marine Leproust
Employees
979
IPO date
Oct 31, 2018
Country
US
Exchange
NASDAQ Global Select
Website
Altman Z-scorei23.99
Piotroski scorei2/9
Overall ratingiC-
Owner earningsi$5.91M$0.09 per share
ESG risk ratingiBIndustry rank: 353/728

Rating factors

Return on equityi
1/5
Return on assetsi
1/5
Debt to equityi
3/5
Price to earningsi
1/5
Price to booki
1/5
Market cap history
$6.47B-28.8%Aug 2026 – Nov 2026
$6.47B$9.63B$12.79BHigh: $12.79B · 2026-10-05Latest: $6.47B · 2026-11-20Aug 2026Sep 2026Oct 2026Nov 2026
Latest: $6.47B · 2026-11-20High: $12.79B · 2026-10-05Low: $6.47B · 2026-11-20

Not comparable with the headline: the provider's history counts about 62.62M shares, the headline 68.18M. Shown as the provider reports it.

Largest fund holders
FundWeightShares held
VTI0.02%2.1M
IWM0.34%1.7M
VB0.16%1.5M
NJM0.13%1.4M
ARKK3.33%1.3M
XBI1.98%1.3M
ARKG8.25%1.2M
VBK0.37%830.7K
FBGKX0.11%779.6K
VXF0.15%746.6K
VEXPX0.64%734.5K
FSSNX0.29%650.2K

Analyst track record

How the analysts covering TWST have done: ratings, price-target accuracy and the measured reaction after their calls.

12 months3 years
Ratings56154
Analysts1318
Buy / hold / sell49 / 5 / 2128 / 17 / 9
Upgrades / downgrades / initiations1 / 1 / 61 / 1 / 10
Price targets hit / missed28 / 22 (56%)122 / 22 (85%)
Avg. return after a rating (TipRanks)+41.2%+116.6%
Best / worst call+186.2% / -48.1%+346.5% / -48.1%

After buy calls on this stock: median 21-day move +4.6% vs S&P 500 +3.7% (n = 126)

Most accurate on this stock

Share of an analyst's price targets on this stock that the price reached within 12 months (our measurement over the last 3 years, at least 8 targets). It describes past calls, not the odds of the current one.

  1. Catherine Ramsey SchulteRobert W. Baird95% hit rate on this stock · 21 targets measuredBuytarget $135Nov 13, 2026
  2. Luke SergottBarclays76% hit rate on this stock · 17 targets measuredBuytarget $130Nov 13, 2026
  3. Brendan SmithTD Cowen50% hit rate on this stock · 12 targets measuredBuytarget $137Nov 13, 2026

Latest ratings

DateAnalystCallTarget
Nov 13, 2026Puneet SoudaLeerink PartnersNov 13, 2026BuyReiterated$175↗
Nov 13, 2026Brendan SmithTD CowenNov 13, 2026BuyReiterated$137↗
Nov 13, 2026Catherine Ramsey SchulteRobert W. BairdNov 13, 2026BuyMaintained$135↗
Nov 13, 2026Luke SergottBarclaysNov 13, 2026BuyMaintained$130↗
Nov 13, 2026Doug SchenkelUBSNov 13, 2026HoldMaintained$120↗
Consensus over the last 12 months buy hold sell avg. target month-end close
Monthly buy, hold and sell shares of analyst ratings with the average price target and the month-end close$20.00$40.00$60.00$80.00$100$120$140$160$180Dec 25 · Buy 7 · Hold 1 · Sell 1Dec 25Jan 26 · Buy 7 · Hold 1 · Sell 1Feb 26 · Buy 7 · Hold 0 · Sell 0Feb 26Mar 26 · Buy 7 · Hold 0 · Sell 0Apr 26 · Buy 7 · Hold 0 · Sell 0Apr 26May 26 · Buy 7 · Hold 0 · Sell 0Jun 26 · Buy 9 · Hold 0 · Sell 0Jun 26Jul 26 · Buy 8 · Hold 1 · Sell 0Aug 26 · Buy 8 · Hold 1 · Sell 0Aug 26Sep 26 · Buy 8 · Hold 3 · Sell 1Oct 26 · Buy 8 · Hold 4 · Sell 1Oct 26Nov 26 · Buy 8 · Hold 4 · Sell 1Dec 25 · avg. target $37.75Jan 26 · avg. target $39.13Feb 26 · avg. target $50.17Mar 26 · avg. target $51.00Apr 26 · avg. target $52.50May 26 · avg. target $64.00Jun 26 · avg. target $82.13Jul 26 · avg. target $96.63Aug 26 · avg. target $112Sep 26 · avg. target $119Oct 26 · avg. target $152Nov 26 · avg. target $129Dec 25 · month-end close $31.72Jan 26 · month-end close $41.07Feb 26 · month-end close $46.92Mar 26 · month-end close $47.52Apr 26 · month-end close $58.45May 26 · month-end close $66.87Jun 26 · month-end close $103Jul 26 · month-end close $91.55Aug 26 · month-end close $139Sep 26 · month-end close $193Oct 26 · month-end close $153Nov 26 · month-end close $103

Share of analysts per call each month (latest call per analyst within 180 days). Targets and closes in USD.

TipRanks data · computed Nov 20, 2026 · 56 ratings

Frequently asked questions

Where can I trade TWST perpetual futures?

Twist Bioscience Corporation (TWST) perpetual futures trade on 16 crypto venues, including Ourbit, LBank, KuCoin. PerpEquities compares them by live price, funding rate, open interest and liquidity.

Can I trade TWST around the clock?

Yes. Unlike the underlying stock, TWST perpetuals trade 24/7 — including weekends and outside regular market hours.

What is the funding rate on TWST perpetuals?

Right now the TWST perp funding rate is 0.0% annualized (venue median), ranging from -6.2% to +194.5% across 16 venues. A positive rate means longs pay shorts. PerpEquities shows the live rate and its history for every venue.

How does the TWST perp price compare to the Twist Bioscience Corporation stock?

The venue-median TWST perp mark is $105.8 versus a reference stock price of $105.8, a basis of 0.0%. Perps follow the stock through an index price; the gap widens when funding or liquidity diverge between venues.

What is a TWST perpetual future?

A TWST perpetual is a derivative that tracks the price of Twist Bioscience Corporation with no expiry date. It lets you take long or short exposure to Twist Bioscience Corporation on crypto venues, around the clock.

What is TWSTUSDT perpetual?

TWSTUSDT is the symbol most crypto exchanges use for the Twist Bioscience Corporation perpetual settled in USDT (Tether). It tracks the TWST share price through an index, trades 24/7 with leverage and never expires.

Embed this asset

TWST perpetuals · perpequities.comTWST perpetuals · perpequities.com
<a href="https://perpequities.com/stocks/twst-perp"><img src="https://perpequities.com/badge/twst-perp.svg" width="240" height="64" alt="TWST perpetuals · perpequities.com" loading="lazy"></a>

Next step

Stay on top of TWST perps

Signals with a track record

Analysts who hit 70%+ of their targets on the perps we track, congress buys over $500k, 13F positions over $5M, funding spreads that have paid for days. Every post shows the evidence. Free, no sign-up.

Join on Telegram

Weekly digest by email

The listings, funding and moves that matter for TWST — one email every Sunday.

Watchlist and alerts

Price and funding alerts for TWST, via push or Telegram.

Set an alert

Follow the live feed

Daily movers, new listings and funding extremes as they happen.

Follow on X